These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19751190)

  • 41. p300 acts as a transcriptional coactivator for mammalian Notch-1.
    Oswald F; Täuber B; Dobner T; Bourteele S; Kostezka U; Adler G; Liptay S; Schmid RM
    Mol Cell Biol; 2001 Nov; 21(22):7761-74. PubMed ID: 11604511
    [TBL] [Abstract][Full Text] [Related]  

  • 42. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
    Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
    Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
    Zang MX; Li Y; Xue LX; Jia HT; Jing H
    J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Notch1 activation enhances proliferation via activation of cdc2 and delays differentiation of myeloid progenitors.
    Nakamura M; Wu L; Griffin JD; Kojika S; Goi K; Inukai T; Sugita K
    Leuk Res; 2018 Sep; 72():34-44. PubMed ID: 30086426
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity.
    Sang N; Avantaggiati ML; Giordano A
    J Cell Biochem; 1997 Sep; 66(3):277-85. PubMed ID: 9257185
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The myogenic regulatory circuit that controls cardiac/slow twitch troponin C gene transcription in skeletal muscle involves E-box, MEF-2, and MEF-3 motifs.
    Christensen TH; Kedes L
    Gene Expr; 1999; 8(4):247-61. PubMed ID: 10794526
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development.
    Creemers EE; Sutherland LB; McAnally J; Richardson JA; Olson EN
    Development; 2006 Nov; 133(21):4245-56. PubMed ID: 17021041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. GATA-dependent recruitment of MEF2 proteins to target promoters.
    Morin S; Charron F; Robitaille L; Nemer M
    EMBO J; 2000 May; 19(9):2046-55. PubMed ID: 10790371
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MEF-2 function is modified by a novel co-repressor, MITR.
    Sparrow DB; Miska EA; Langley E; Reynaud-Deonauth S; Kotecha S; Towers N; Spohr G; Kouzarides T; Mohun TJ
    EMBO J; 1999 Sep; 18(18):5085-98. PubMed ID: 10487760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The transcriptional coregulator MAML1 affects DNA methylation and gene expression patterns in human embryonic kidney cells.
    Putnik M; Brodin D; Wojdacz TK; Fagerström-Billai F; Dahlman-Wright K; Wallberg AE
    Mol Biol Rep; 2016 Mar; 43(3):141-50. PubMed ID: 26857655
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MEF2: a central regulator of diverse developmental programs.
    Potthoff MJ; Olson EN
    Development; 2007 Dec; 134(23):4131-40. PubMed ID: 17959722
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 14-3-3tau associates with and activates the MEF2D transcription factor during muscle cell differentiation.
    Choi SJ; Park SY; Han TH
    Nucleic Acids Res; 2001 Jul; 29(13):2836-42. PubMed ID: 11433030
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Dynamic Role of Mastermind-Like 1: A Journey Through the Main (Path)ways Between Development and Cancer.
    Zema S; Pelullo M; Nardozza F; Felli MP; Screpanti I; Bellavia D
    Front Cell Dev Biol; 2020; 8():613557. PubMed ID: 33425921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling.
    Kitagawa H; Ray WJ; Glantschnig H; Nantermet PV; Yu Y; Leu CT; Harada S; Kato S; Freedman LP
    Mol Cell Biol; 2007 Nov; 27(21):7486-96. PubMed ID: 17709391
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ICAT inhibits beta-catenin binding to Tcf/Lef-family transcription factors and the general coactivator p300 using independent structural modules.
    Daniels DL; Weis WI
    Mol Cell; 2002 Sep; 10(3):573-84. PubMed ID: 12408825
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation.
    Ma K; Chan JK; Zhu G; Wu Z
    Mol Cell Biol; 2005 May; 25(9):3575-82. PubMed ID: 15831463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual roles for MEF2A and MEF2D during human macrophage terminal differentiation and c-Jun expression.
    Aude-Garcia C; Collin-Faure V; Bausinger H; Hanau D; Rabilloud T; Lemercier C
    Biochem J; 2010 Sep; 430(2):237-44. PubMed ID: 20590529
    [TBL] [Abstract][Full Text] [Related]  

  • 58. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor.
    De Luca A; Severino A; De Paolis P; Cottone G; De Luca L; De Falco M; Porcellini A; Volpe M; Condorelli G
    Biochem J; 2003 Feb; 369(Pt 3):477-84. PubMed ID: 12371907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Smad proteins function as co-modulators for MEF2 transcriptional regulatory proteins.
    Quinn ZA; Yang CC; Wrana JL; McDermott JC
    Nucleic Acids Res; 2001 Feb; 29(3):732-42. PubMed ID: 11160896
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanism of recruitment of class II histone deacetylases by myocyte enhancer factor-2.
    Han A; He J; Wu Y; Liu JO; Chen L
    J Mol Biol; 2005 Jan; 345(1):91-102. PubMed ID: 15567413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.